AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination - Reuters
AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxNMVNoZTkwVjRoUjd3eHBBRmNaenRuM1RmODZBd2dYd0ZPZ0Q4Nmtmc2xTc2VpZ2M0dE93UHFrc0h1dzZqREtOcHFlRUZrNXJmTl83ME0xdVNhLWhkdTRDeGZvWm1ZZTFGWUxhSHNsX19qc09US25qSmZKZUYtOWtZZHR6YmMta3VaYm01b0dOczBFMEc5X2xSUkJJbUFhQVhRQ2g0c0VCUTZEYVMxRWV6VzBBS0ZULUpESnlpVk0wa1RyZ1lZSmxv?oc=5" target="_blank">AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
AstraZeneca to invest $2 billion in Summit Therapeutics for cancer drug tie-up - Reuters
AstraZeneca to invest $2 billion in Summit Therapeutics for cancer drug tie-up Reuters
September 28, 2026 at 10:15 PMMerck licenses SciBrunch cancer drug in deal worth up to $2.13 billion - Reuters
Merck licenses SciBrunch cancer drug in deal worth up to $2.13 billion Reuters
September 28, 2026 at 04:14 PMExperimental Lilly combination drug tops Zepbound in weight-loss trial - Reuters
Experimental Lilly combination drug tops Zepbound in weight-loss trial Reuters
September 30, 2026 at 05:34 PMAbbVie joins US government pilot to test drug discount rebates - Reuters
AbbVie joins US government pilot to test drug discount rebates Reuters
October 2, 2026 at 08:53 PMNovartis strikes up to $7.8 billion mRNA deal with China's Abogen - Reuters
Novartis strikes up to $7.8 billion mRNA deal with China's Abogen Reuters
October 2, 2026 at 10:57 AMUniQure plunges as Huntington's trial data disappoints investors - reuters.com
UniQure plunges as Huntington's trial data disappoints investors reuters.com
September 29, 2026 at 10:11 PM